Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
dietary supplement nootropic |
| gptkbp:abbreviation |
Acetyl-L-carnitine
|
| gptkbp:administeredBy |
oral
intravenous |
| gptkbp:approvedBy |
peripheral neuropathy (in some countries)
|
| gptkbp:CASNumber |
5080-50-2
|
| gptkbp:category |
amino acid derivative
quaternary ammonium compound |
| gptkbp:chemicalClass |
Acetyl-L-carnitine
|
| gptkbp:discoveredIn |
20th century
|
| gptkbp:effect |
antioxidant
neuroprotective mitochondrial function support |
| gptkbp:excretion |
kidneys
|
| gptkbp:foundIn |
dietary supplements
|
| gptkbp:hasMolecularFormula |
C9H17NO4
|
| https://www.w3.org/2000/01/rdf-schema#label |
ALCAR
|
| gptkbp:metabolism |
liver
|
| gptkbp:predecessor |
gptkb:acetylcholine
|
| gptkbp:relatedTo |
L-carnitine
|
| gptkbp:sideEffect |
nausea
restlessness insomnia |
| gptkbp:usedFor |
gptkb:Alzheimer's_disease
gptkb:depression fatigue peripheral neuropathy cognitive enhancement |
| gptkbp:bfsParent |
gptkb:CARMAT
|
| gptkbp:bfsLayer |
7
|